Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Korro Bio, Inc. - Common Stock (NQ: KRRO )

35.97 +0.71 (+2.00%)
Streaming Delayed Price Updated: 11:38 AM EST, Jan 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 31,735
Open 35.69
Bid (Size) 35.73 (1)
Ask (Size) 36.20 (3)
Prev. Close 35.26
Today's Range 34.75 - 36.00
52wk Range 30.00 - 98.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors
Industry veterans John Maraganore, Ph.D., and Rachel Meyers, Ph.D., to provide strategic guidance on the company’s RNA Actuating platform to develop a new class of RNA medicines that upregulate protein... 
From CAMP4 Therapeutics
Via GlobeNewswire
This TechnipFMC Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga

Performance

YTD
-12.32%
-12.32%
1 Month
-23.28%
-23.28%
3 Month
-8.37%
-8.37%
6 Month
-26.97%
-26.97%
1 Year
-22.99%
-22.99%

More News

Read More
Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space.
Via Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
United Airlines Posts Upbeat Earnings, Joins Morgan Stanley, U.S. Bancorp And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
3 Stocks That Could Rise on European Bank Interest Rate Cuts
Via MarketBeat
Topics Economy
Exposures Interest Rates
Novo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks
Via The Motley Fool
Novo Nordisk Inks $600M Genetic Medicines Pact With Canadian Firm To Target Cardiometabolic Indications
Via Benzinga
Gold Edges Lower; US Homebuilder Sentiment Rises For September
Via Benzinga
Crude Oil Gains Over 1%; US Business Inventories Increase In July
Via Benzinga
Exposures Fossil Fuels
Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating
Via Benzinga
KRRO Stock Earnings: Korro Bio Misses EPS for Q2 2024
Via InvestorPlace
KRRO Stock Earnings: Korro Bio Beats EPS for Q4 2023
Via InvestorPlace
KRRO Stock Earnings: Korro Bio Beats EPS for Q1 2024
Via InvestorPlace
Ecolab Posts Strong Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Why Newly Listed Korro Bio Shares Are Gaining Today
Via Benzinga
These 3 Biotech Stocks More Than Doubled in November. Can They Fly Even Higher in 2024?
Via The Motley Fool
Chegg, Perdoceo Education And Other Big Stocks Moving Lower On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.